Cardiff Oncology, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
CRDF chart
What traders are saying about $CRDF
Latest postsCardiff Oncology, Inc. news
- Experimental drug for rare leukemia wins FDA orphan drug status
Rare Cancer News ·
- Cardiff Oncology, Inc. Estimates – NASDAQ:CRDF
TradingView ·
- FDA Grants Orphan Drug Designation to Onvansertib for Chronic Myelomonocytic Leukemia
OncLive ·
- Cardiff Oncology Inc. R (XE7C.DU) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- CRDF Q3'26 Earnings: revenue estimate is 81.43K USD
TradingView ·
- FDA grants Orphan Drug Designation to onvansert...
Pluang ·
- Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
Yahoo Finance ·
- FDA gives a drug for a rare blood cancer special status that may bring trial tax credits.
Stock Titan ·
- 3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets
Yahoo Finance ·
- Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
Yahoo Finance ·
- Cardiff Oncology to Participate in September 2026 Conferences
Yahoo Finance ·
- CRDF: Second Quarter Earnings
Yahoo Finance ·
Cardiff Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $593,000 | $683,000 | $488,000 | $386,000 |
| Net income | -$45,851 | -$45,431 | -$41,441 | -$38.7M |
| Diluted EPS | $-0.69 | $-0.95 | $-0.93 | $-0.89 |
| Total assets (year end) | $61.9M | $97.2M | $81.6M | $116.2M |
| Cash and equivalents (year end) | $17.5M | $51.5M | $21.7M | $16.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cardiff Oncology, Inc.
- Ticker
- CRDF (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1213037
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC
Frequently asked questions
What exchange is Cardiff Oncology, Inc. listed on?
Cardiff Oncology, Inc. trades on the Nasdaq under the ticker symbol CRDF.
What industry is Cardiff Oncology, Inc. in?
Cardiff Oncology, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Cardiff Oncology, Inc. headquartered?
Cardiff Oncology, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Cardiff Oncology, Inc.'s fiscal year end?
Cardiff Oncology, Inc.'s fiscal year ends on December 31.
How much revenue did Cardiff Oncology, Inc. report?
Cardiff Oncology, Inc. reported $593,000 in revenue for calendar year 2025, according to its SEC filings.